In a 23-year-long, large-scale study involving patients with either MPO- or PR3-ANCA vasculitis, kidney, lung, and gastrointestinal involvement were reported in only 114, 72, and 5 patients, respectively, thus highlighting the rarity of these complications [9]. This evidence concerns the gene MPO and vasculitis.